PSMB8 and bacterial infectious disease: To this end, we subjected WT and β5i/LMP7 KO primary microglia to treatment with bortezomib (BTZ, inhibits overall chymotrypsin-like activity) and toll-like receptor (TLR) 4 ligand lipopolysaccharide (LPS, mimics bacterial infection and stimulates inflammation).